MACKENZIE FINANCIAL CORP
Position in PAHC — Phibro Animal Health Corp
CIK 919859
TORONTO ONTARIO, A6
Position in PAHC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,150,683
+$2,259,558 QoQ
Shares Held
75,044
+48.3% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in PAHC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,150,683 | 75,044 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,891,125 | 50,619 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,912,301 | 47,264 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $941,225 | 36,853 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $215,842 | 10,105 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $477,729 | 22,749 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||